gour-medical.com
Agreement with Iddex Laboratories
GOUR MEDICAL SA announced today that it has entered into an exclusive license agreement with IDEXX Laboratories, Inc. to continue the development of a recombinant monoclonal antibody for therapeutic use: anti-IgE chimeric antibody for the treatment of canine allergy. December 21st, 2015 ZUG, Switzerland - Gour Medical SA, a